AI assistant
CANN GROUP LIMITED — Capital/Financing Update 2024
Nov 19, 2024
64603_rns_2024-11-19_699d8d20-5f16-4ef1-8ee5-471ae97b3136.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [114 x 53] intentionally omitted <==
ASX ANNOUNCEMENT
20 November 2024
Entitlement Offer Closing Monday, 25 November 2024
20 November 2024 – Cann Group Limited (ASX: CAN) ( Cann or the Company ) refers to the Non-renounceable Entitlement Offer, as set out in the Prospectus and Supplementary Prospectus lodged with ASIC and ASX, on Monday, 7 October 2024 and Wednesday, 23 October 2024 respectively ( Offer ).
The Company would like to remind Eligible Shareholders that per the timeline, the offer will close at:
5.00pm (Melbourne time), Monday, 25 November 2024.
Offer Timeline
The timetable for the Offer is set out below:
| Event | Date |
|---|---|
| Lodgement of Supplementary Prospectus with the ASIC | Wednesday, 23 October 2024 |
| Last day to extend the Offer Closing Date | Wednesday, 20 November 2024 |
| Last date to withdraw Applications | Monday, 25 November 2024 |
| Offer and Lead Manager Offer Closing Date (at 5:00pm Melbourne time) |
Monday, 25 November 2024 |
| New Shares under the Offer quoted on a deferred settlement basis |
Tuesday, 26 November 2024 |
| Notification of results of Offer | Thursday, 28 November 2024 |
| Issue of New Shares and New Options under Offer and deferred settlement trading ends |
Monday, 2 December 2024 |
| Anticipated date for despatch of holding statements for New Shares and New Options under Offer |
Tuesday, 3 December 2024 |
| Last day for issuing Lead Manager Options (subject to successful Shortfall Placement) |
Tuesday, 25 February 2025 |
Your Application Monies must be remitted so as to be received by the Share Registry by BPAY® by 5:00PM (AEST) on Monday, 25 November 2024. If you do not make a BPAY payment, your application will be incomplete and will not be accepted.
Cann Group Limited ABN 25 603 949 739, Australia 262-276 Lorimer Street, Port Melbourne, Victoria, 3207, Australia Tel +61 (0) 3 9095 7088 | www.canngrouplimited.com
How to Participate
The Offer website can be accessed at https://www.canngrouplimited.com/home/. A copy of the Prospectus and Supplementary Prospectus and your online personalised Entitlement and Acceptance form are available on the Offer website. Eligible Shareholders should read the Prospectus and Supplementary Prospectus together and in their entirety before deciding whether to participate in the Offer.
To accept the Offer via the Offer website, Eligible Shareholders will need to follow these steps:
Step 1: Access the Offer website via https://www.canngrouplimited.com/home/.
Step 2: Enter your country of residence and accept the terms and conditions.
Step 3: Download the Prospectus and Supplementary Prospectus and read them.
Step 4: Verify your details by entering your Securityholder Reference Number (SRN) or Holder Identification Number (HIN) and your postcode to access your personalised Entitlement and Acceptance Form.
Step 5: Complete the Entitlement and Acceptance Form online and make payment using BPAY and the unique payment reference number provided (for Eligible Shareholders with an Australian bank account) or using the electronic funds transfer (i.e., Direct Credit) details provided in your Entitlement and Acceptance Form (for Eligible Shareholders with a residential address in New Zealand only).
Alternatively, Eligible Shareholders who received or requested a hard copy personalised Entitlement and Acceptance Form may also accept the Offer:
-
for Eligible Shareholders with an Australian bank account only, by:
-
completing and returning a hard copy of their personalised Entitlement and Acceptance Form together with payment by cheque, bank draft or money order in Australian dollars; or
-
paying via BPAY® in accordance with the instructions on their personalised Entitlement and Acceptance Form (without needing to complete and return their personalised Entitlement and Acceptance Form); or
-
for Eligible Shareholders with a residential address in New Zealand only, by paying via electronic funds transfer and then submitting their personalised Entitlement and Acceptance Form to the email address specified on their personalised Entitlement and Acceptance Form.
For further information regarding the Offer please contact your stockbroker or professional adviser, or Mr Steven Notaro, Cann Group Limited Company Secretary on +61 3 9095 7088.
The Company welcomes the support it has received from shareholders for the Offer to date and looks forward to completing this important capital raise.
2 | P a g e
Authorised for release by the Board of Directors, Cann Group Limited.
For all other information please contact:
Jenni Pilcher Steven Notaro CEO & Managing Director Company Secretary Cann Group Limited Cann Group Limited +61 3 9095 7088 +61 3 9095 7088 [email protected] [email protected]
About Cann Group
Cann Group Limited (ABN 25 603 949 739) is enhancing patients’ lives by developing, producing, and supplying innovative cannabis medicines. The Company has research facilities and corporate headquarters in Melbourne and operates a state-of-the-art large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. Cann Group also owns Satipharm and its patent-protected capsule technology.
Learn more at: www.canngrouplimited.com | www.satipharm.com
3 | P a g e